Roger Barker (Former)
41 – 50 of 130
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
α-Synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell function
(
- Contribution to journal › Article
-
Mark
A PBX1 transcriptional network controls dopaminergic neuron development and is impaired in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Making it personal : the prospects for autologous pluripotent stem cell-derived therapies
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Atomoxetine restores the response inhibition network in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Learning to be inflexible : Enhanced attentional biases in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Exogenous melatonin for Parkinson's disease: 'Waking up' to the need for further trials
(
- Contribution to journal › Letter
-
Mark
Setting Global Standards for Stem Cell Research and Clinical Translation : The 2016 ISSCR Guidelines
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Aberrant nigral diffusion in Parkinson's disease : A longitudinal diffusion tensor imaging study
(
- Contribution to journal › Article
-
Mark
Cognitive decline and quality of life in incident Parkinson's disease : The role of attention
(
- Contribution to journal › Article